You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for NDC 46122-0683


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 46122-0683

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 46122-0683

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to first understand what the NDC represents. The National Drug Code (NDC) is a unique, 10-digit, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code[1][5].

Breaking Down the NDC: 46122-0683

  • Labeler Code: The first segment (46122) identifies the firm that manufactures, repackages, or distributes the drug.
  • Product Code: The second segment (068) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment (3) identifies the package size and type.

Market Context

Pharmaceutical Industry Outlook

The pharmaceutical industry, particularly the generic drug sector, is expected to experience mid-single-digit percent annual price erosion in 2024. However, there is also a forecast of modest revenue growth, which is an improvement from recent trends[3].

Drug Reconstitution Market

For drugs that require reconstitution, such as lyophilized formulations, the market is growing. This segment is expected to see significant growth due to the increasing number of biologic and small molecule drugs that are not stable in liquid form. The drug reconstitution market is projected to grow at a CAGR of 8% from 2021 to 2035[4].

Price Projections

Generic Drug Price Erosion

Given that the NDC 46122-0683 likely pertains to a generic or branded drug, it is important to consider the broader market trends. For generic drugs, mid-single-digit percent annual price erosion is anticipated. This means that the price of the drug could decrease by around 3-5% annually[3].

Specific Drug Pricing

To provide a more precise price projection, we need to identify the specific drug associated with the NDC 46122-0683. However, without the exact drug name and its current market price, we can only speculate based on general trends.

  • Current Pricing: If the drug is currently priced at $X per unit, considering the generic drug price erosion trend, it might decrease to $X 0.95 (or $X 0.98 for a 2% erosion) in the next year.
  • Revenue Growth: Despite price erosion, the overall revenue for the drug could still grow if the demand increases or if the manufacturer manages to increase sales volume.

Market Analysis

Demand and Supply Dynamics

The demand for the drug will be influenced by factors such as the prevalence of the condition it treats, competition from other drugs, and changes in healthcare policies. For instance, if the drug is used to treat a chronic condition with an increasing patient population, demand might rise despite price erosion.

Competitive Landscape

The competitive landscape in the pharmaceutical industry is intense, especially in the generic drug sector. New entrants, biosimilars, and innovative formulations can all impact the market share and pricing of existing drugs. For the drug with NDC 46122-0683, understanding its position within this landscape is crucial for accurate market analysis.

Regulatory and Legal Considerations

FDA Inspections and Litigation

The pharmaceutical industry faces potential risks such as increased FDA inspections of foreign manufacturing facilities and ongoing price-fixing litigation. These factors can impact the supply chain and pricing of drugs, including those identified by the NDC 46122-0683[3].

Example of Similar Drugs

To illustrate the potential price movements, let's consider a hypothetical example of a drug with similar characteristics:

  • Drug X: If Drug X, which is in the same therapeutic class as the drug with NDC 46122-0683, is currently priced at $100 per unit and experiences a 3% annual price erosion, its price would decrease to $97 in the next year.

Key Takeaways

  • NDC Structure: The NDC is a unique identifier consisting of a labeler code, product code, and package code.
  • Price Erosion: Generic drugs are expected to experience mid-single-digit percent annual price erosion.
  • Revenue Growth: Despite price erosion, revenue can grow due to increased demand or sales volume.
  • Market Dynamics: Demand and supply factors, along with the competitive landscape, significantly influence the market and pricing of drugs.
  • Regulatory Risks: FDA inspections and litigation can impact the pharmaceutical industry's pricing and supply chain.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, 10-digit number that identifies a drug product, including the labeler, specific strength, dosage form, and package size.

Q: How is the NDC structured? A: The NDC consists of three segments: the labeler code, product code, and package code, configured in one of the following formats: 4-4-2, 5-3-2, or 5-4-1.

Q: What are the expected price trends for generic drugs in 2024? A: Generic drugs are expected to experience mid-single-digit percent annual price erosion, but with modest revenue growth.

Q: How does the drug reconstitution market impact pharmaceutical pricing? A: The growing demand for reconstitution systems, especially for lyophilized drugs, can influence the pricing and market dynamics of these drugs.

Q: What are the potential risks for the pharmaceutical industry in 2024? A: Potential risks include increased FDA inspections of foreign manufacturing facilities and ongoing price-fixing litigation.

Sources

  1. FDA: National Drug Code Database Background Information.
  2. Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
  3. S&P Global: Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures.
  4. Roots Analysis: Drug Reconstitution Market Size, Share, Trends, Forecast (2035).
  5. YouTube: NDC Directory (March 2015).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.